2 completed. 2 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Completed 2 |
Follow XPF-008: new trials by email Literature Review of XPF-008 trials Research Report on XPF-008
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Safety, Tolerability, Pharmacokinetics and Effects on Transcranial Magnetic Stimulation of Oral Doses of XEN1101 XPF-008, Microcrystalline Cellulose - Healthy Male Volunteers | Phase 1 | Completed | Xenon Pharmaceuticals Inc. | 20 | 2018-02-13 | 2018-09-18 |
| Safety, Tolerability, and Pharmacokinetics (PK) of Single and Multiple Ascending Oral Doses of XEN1101. XPF-008, Microcrystalline Cellulose, XPF-010 - Healthy Volunteers | Phase 1 | Completed | Xenon Pharmaceuticals Inc. | 130 | 2017-11-13 | 2023-05-11 |
Xenon Pharmaceuticals Inc. (2)
United Kingdom (2)
Gregory Beatch, PhD (1) · Gregory N Beatch, PhD (1)
2017 (2)